BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24475257)

  • 21. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.
    Iversen LV; Ostergaard O; Nielsen CT; Jacobsen S; Heegaard NH
    J Immunol Methods; 2013 Feb; 388(1-2):49-59. PubMed ID: 23246793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemia.
    Brunetta DM; De Santis GC; Silva-Pinto AC; Oliveira de Oliveira LC; Covas DT
    Acta Haematol; 2015; 133(3):287-94. PubMed ID: 25472687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum zinc level during and after acute painful episodes in children with sickle cell anemia at the aminu kano teaching hospital, Kano, Northern Nigeria.
    Kudirat AA; Shehu UA; Kolade E; Ibrahim M
    Niger J Clin Pract; 2019 Jan; 22(1):16-23. PubMed ID: 30666015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.
    Camus SM; De Moraes JA; Bonnin P; Abbyad P; Le Jeune S; Lionnet F; Loufrani L; Grimaud L; Lambry JC; Charue D; Kiger L; Renard JM; Larroque C; Le Clésiau H; Tedgui A; Bruneval P; Barja-Fidalgo C; Alexandrou A; Tharaux PL; Boulanger CM; Blanc-Brude OP
    Blood; 2015 Jun; 125(24):3805-14. PubMed ID: 25827830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial activation by platelets from sickle cell anemia patients.
    Proença-Ferreira R; Brugnerotto AF; Garrido VT; Dominical VM; Vital DM; Ribeiro Mde F; dos Santos ME; Traina F; Olalla-Saad ST; Costa FF; Conran N
    PLoS One; 2014; 9(2):e89012. PubMed ID: 24551209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Microparticles in Children With Sickle Cell Anemia in a Tertiary Center in Upper Egypt.
    Zahran AM; Elsayh KI; Saad K; Embaby MM; Youssef MAM; Abdel-Raheem YF; Sror SM; Galal SM; Hetta HF; Aboul-Khair MD; Alblihed MA; Elhoufey A
    Clin Appl Thromb Hemost; 2019; 25():1076029619828839. PubMed ID: 30740989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
    Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
    Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia.
    Wun T; Paglieroni T; Tablin F; Welborn J; Nelson K; Cheung A
    J Lab Clin Med; 1997 May; 129(5):507-16. PubMed ID: 9142047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment.
    Piccin A; Murphy C; Eakins E; Rondinelli MB; Daves M; Vecchiato C; Wolf D; Mc Mahon C; Smith OP
    Eur J Haematol; 2019 Apr; 102(4):319-330. PubMed ID: 30664257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis.
    Papadimitriou CA; Travlou A; Kalos A; Douratsos D; Lali P
    Acta Haematol; 1993; 89(4):180-3. PubMed ID: 8212998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased phosphatidylserine-exposing microparticles and their originating cells are associated with the coagulation process in patients with IgA nephropathy.
    He Z; Zhang Y; Cao M; Ma R; Meng H; Yao Z; Zhao L; Liu Y; Wu X; Deng R; Dong Z; Bi Y; Kou J; Novakovic V; Shi J; Hao L
    Nephrol Dial Transplant; 2016 May; 31(5):747-59. PubMed ID: 26673909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum copeptin and cortisol do not accurately predict sickle cell anaemia vaso-occlusive crisis as C-reactive protein.
    Akinlade KS; Atere AD; Olaniyi JA; Rahamon SK; Adewale CO
    PLoS One; 2013; 8(11):e77913. PubMed ID: 24223742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.
    Garrido VT; Proença-Ferreira R; Dominical VM; Traina F; Bezerra MA; de Mello MR; Colella MP; Araújo AS; Saad ST; Costa FF; Conran N
    Br J Haematol; 2012 Sep; 158(6):788-97. PubMed ID: 22775554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
    Christersson C; Johnell M; Siegbahn A
    Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.
    Wagdy R; Suliman H; Bamashmose B; Aidaroos A; Haneef Z; Samonti A; Awn F
    Eur J Pediatr; 2018 Dec; 177(12):1745-1752. PubMed ID: 30194527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia.
    Lee K; Gane P; Roudot-Thoraval F; Godeau B; Bachir D; Bernaudin F; Cartron JP; Galactéros F; Bierling P
    Blood; 2001 Aug; 98(4):966-71. PubMed ID: 11493440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
    Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
    J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased microparticle levels in middle-aged and elderly patients with insomnia may be involved in the pathogenesis of arteriosclerosis.
    Xu B; Ma L; Zhang N; Guo W; Luo LM; Wang C; Jiang Y; Liu LG
    Int Angiol; 2020 Jun; 39(3):252-260. PubMed ID: 32052947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.